1
1978. Dr. Gustavo Bounous initiated a novel research program in conjunction with colleagues, including Dr. Patricia Kongshavn, from McGill University, to search for a dietary protein source that would optimize the immune system. 1981. Dr. Gustavo Bounous and Dr. Patricia Kongshavn are the first to discover the effect of whey protein on the immune system. 1986. Dr. Wulf Dröge described the effect of glutathione on the immune response of a living organism. 1988. Dr. Gustavo Bounous and Dieter Beer initiate close association. Launch Immunotec Research Corp. 1988. Dr. Wulf Dröge discovers the abnormally low cysteine and glutathione levels in HIV patients. 1994. Dr. Luc Montagnier (future Nobel Prize winner) drew attention to the promising effects of Immunocal, in his opening address at the 10 th International AIDS Conference in Yokohama, Japan. 1996. Immunotec Research Corp. merges with Chuck Roberts’ company, Roberts Evergreen Products Ltd., and John Molson and forms Immunotec Research Ltd. 1996. Official Canadian launch. 1997. Official American launch. 1997. Drs. Montagnier, Olivier and Pasquier edit the book Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases, devoting an entire chapter to a paper on Immunocal. 1998. Dr. Jimmy Gutman writes his first book on glutathione, The Ultimate GSH Handbook. 1999. Dr. Bounous’ story, Breakthrough in Cell-Defense is written by Dr. Allan Somersall. 1999. Immunocal listed in the highly respected U.S. Physicians’ Desk Reference (PDR). 1999. Dr. Larry Lands publishes first paper on sports performance. 2001. Immunotec partners with Consultants to build 10 Casa Immunotec homes in Honduras. 2003. The first Immunotec Consultant earns a million dollars. 2005. World renowned immunologist Dr. Wulf Dröge joins Immunotec as Senior Vice-President, Research & Development. 2005. Immunotec moves to its new 37,000 sq. ft. headquarters and 1,000 Consultants celebrate the Grand Opening. 2006. Dr. Dröge launches Immunocal Platinum, the next generation of Immunocal, with CMP and RMF which helps to maintain proper muscle function and bone health by reducing calcium loss. 34 35 Immunotec Milestones 2007. Immunotec Inc. goes public, trading on the TSX Venture exchange under the ticker symbol, IMM. 2007. Immunotec receives regulatory approval from Health Canada to market Immunocal with the health claim: “A natural source of the glutathione precursor cysteine for the maintenance of a strong immune system.” 2008. “HMS 90” becomes “Immunocal” in Canada. 2008. Immunocal sample is tested as part of ConsumerLab.com’s Athletic Banned Substance Screening Program based on the 2007 World Anti-Doping Code Prohibited List and is certified free of any prohibited substances. 2008. Immunotec announces the successful completion of a clinical trial on cancer-related weight loss in lung cancer patients. The research concluded that patients treated with Immunocal showed significant increases in muscle mass and quality of life. 2009. Immunocal first appears in Canadian Compendium of Pharmaceuticals and Specialties (CPS). 2009. Immunotec announces that the Natural Health Products Directorate, a division of Health Canada responsible for evaluating the safety, efficacy and quality of natural health products (NHPs) – granted authorization for Immunotec to conduct a clinical trial of Immunocal in elderly persons. 2010. Immunotec opens market in Mexico. 2012. Opening of new offices in Mexico City. 2012. Glutathione research papers surpass 100,000 articles on PubMed.gov. 2012. Adam Biel, cyclist and Immunotec Consultant cycles from South America, through Central America, United States and Canada. He is fundraising for autism and is powered by Immunocal. 2012. Athletes powered by Immunocal win medals in London Olympic Games. 2013. Immunotec launches the MiForm Weight Management System. MiForm is the next generation in weight management and permanent lifestyle changes. 2013. Immunotec named official sponsor of Rowing Canada. 2014. New sales office opens in California. 2015. Immunotec is recognized as a Top 50 Direct Selling company in Canada and the U.S. and a Top 100 worldwide for 2014. 2015. Immunotec receives regulatory approval from Health Canada to market Immunocal with the health claim:“Helps increase muscle strength and enhance performance when combined with regular exercise.”

immunotecarticle_ImmunotecMilestones_EN

Embed Size (px)

Citation preview

Page 1: immunotecarticle_ImmunotecMilestones_EN

1978. Dr. Gustavo Bounous initiated a novel research program in conjunction

with colleagues, including Dr. Patricia Kongshavn, from McGill University, to search for a dietary protein source that would optimize the immune system.

1981. Dr. Gustavo Bounous and Dr. Patricia Kongshavn are the first to discover the effect of whey protein on the immune system.

1986. Dr. Wulf Dröge described the effect of glutathione on the immune response of a living organism.

1988. Dr. Gustavo Bounous and Dieter Beer initiate close association. Launch Immunotec Research Corp.

1988. Dr. Wulf Dröge discovers the abnormally low cysteine and glutathione levels in HIV patients.

1994. Dr. Luc Montagnier (future Nobel Prize winner) drew attention to the promising effects of Immunocal, in his opening address at the 10th International AIDS Conference in Yokohama, Japan.

1996. Immunotec Research Corp. merges with Chuck Roberts’ company, Roberts Evergreen Products Ltd., and John Molson and forms Immunotec Research Ltd.

1996. Official Canadian launch.

1997. Official American launch.

1997. Drs. Montagnier, Olivier and Pasquier edit the book Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases, devoting an entire chapter to a paper on Immunocal.

1998. Dr. Jimmy Gutman writes his first book on glutathione, The Ultimate GSH Handbook.

1999. Dr. Bounous’ story, Breakthrough in Cell-Defense is written by Dr. Allan Somersall.

1999. Immunocal listed in the highly respected U.S. Physicians’ Desk Reference (PDR).

1999. Dr. Larry Lands publishes first paper on sports performance.

2001. Immunotec partners with Consultants to build 10 Casa Immunotec homes in Honduras.

2003. The first Immunotec Consultant earns a million dollars.

2005. World renowned immunologist Dr. Wulf Dröge joins Immunotec as Senior Vice-President, Research & Development.

2005. Immunotec moves to its new 37,000 sq. ft. headquarters and 1,000 Consultants celebrate the Grand Opening.

2006. Dr. Dröge launches Immunocal Platinum, the next generation of Immunocal, with CMP and RMF which helps to maintain proper muscle function and bone health by reducing calcium loss.

34 35

Immunotec Milestones2007. Immunotec Inc. goes public, trading on the TSX Venture exchange under the ticker symbol, IMM.

2007. Immunotec receives regulatory approval from Health Canada to market Immunocal with the health claim: “A natural source of the glutathione precursor cysteine for the maintenance of a strong immune system.”

2008. “HMS 90” becomes “Immunocal” in Canada.

2008. Immunocal sample is tested as part of ConsumerLab.com’s Athletic Banned Substance Screening Program based on the 2007 World Anti-Doping Code Prohibited List and is certified free of any prohibited substances.

2008. Immunotec announces the successful completion of a clinical trial on cancer-related weight loss in lung cancer patients. The research concluded that patients treated with Immunocal showed significant increases in muscle mass and quality of life.

2009. Immunocal first appears in Canadian Compendium of Pharmaceuticals and Specialties (CPS).

2009. Immunotec announces that the Natural Health Products Directorate, a division of Health Canada responsible for evaluating the safety, efficacy and quality of natural health products (NHPs) – granted authorization for Immunotec to conduct a clinical trial of Immunocal in elderly persons.

2010. Immunotec opens market in Mexico.

2012. Opening of new offices in Mexico City.

2012. Glutathione research papers surpass 100,000 articles on PubMed.gov.

2012. Adam Biel, cyclist and Immunotec Consultant cycles from South America, through Central America, United States and Canada. He is fundraising for autism and is powered by Immunocal.

2012. Athletes powered by Immunocal win medals in London Olympic Games.

2013. Immunotec launches the MiForm Weight Management System. MiForm is the next generation in weight management and permanent lifestyle changes.

2013. Immunotec named official sponsor of Rowing Canada.

2014. New sales office opens in California.

2015. Immunotec is recognized as a Top 50 Direct Selling company in Canada and the U.S. and a Top 100 worldwide for 2014.

2015. Immunotec receives regulatory approval from

Health Canada to market Immunocal with the health claim:“Helps increase muscle strength and enhance performance when combined with regular exercise.”